Ubix Therapeutics
Transforming Medicine to Transform Lives
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- ubixtrx.com
About
Ubix Therapeutics is a South Korean biopharmaceutical company focused on developing novel small molecule therapeutics using targeted protein degradation technology. Founded in 2018, the company advances drug discovery programs across oncology and other therapeutic areas, with a pipeline leveraging medicinal chemistry and translational research expertise. Ubix's leadership team brings experience from organizations including Genexine, SK Chemicals, Huons, and major academic institutions.
Summary
Ubix Therapeutics is a Biotech company, founded in 2018.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ubix-therapeutics"><img src="https://indexed.vc/api/badge/company/ubix-therapeutics" alt="Ubix Therapeutics on Indexed.vc" width="260" height="76" /></a>